Skip to main content

Table 2 Number of patients who received dose escalation during VDC/IE

From: Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review

 

Escalated

Dose unchanged

Dose reduced

Number

VDC

    

  C1

   

23

  C3

10

10

3

23

  C5

3

19

1

23

  Any cycle

10

10

3

23

IE

    

  C2

   

23

  C4

10

11

2

23

  C6

3

19

0

22

  Any cycle

12

9

2

23

Back to article page

Clinical Sarcoma Research

ISSN: 2045-3329